CDC to use T2 Biosystems in testing for superbug Candida auris
T2 Biosystems Inc. (NSDQ:TTOO) said today that the US Centers for Disease Control and Prevention will use its T2Dx Instrument to test and monitor for the emergence and outbreaks of the antibiotic-resistant superbug Candida auris.
The Lexington, Mass.-based company said the use of the T2Dx “represents multiple, new applications” for the platform. The system will be used for the 1st time to test patient skin and blood samples and also for environmental surveillance and to monitor outbreaks.
Both applications are currently available as research tools for investigational purposes in the US and Europe, T2 Biosystem...
Source: Mass Device - September 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics T2 Biosystems Inc. Source Type: news
Candida cleanse diet: What does it treat?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - September 6, 2017 Category: Consumer Health News Source Type: news
Candida Auris: A New Fungal Superbug Emerging As A Global Threat
For the first time, a new yeast, Candida auris, is found to be spreading from person to person in hospitals. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 24, 2017 Category: Pharmaceuticals Authors: Judy Stone, Contributor Tags: NYSE:PFE NYSE:MRK Source Type: news
The Unexpected and Troubling Rise of Candida auris The Unexpected and Troubling Rise of Candida auris
Behaving like a multidrug-resistant microbe, C auris is spreading rapidly throughout the world, including in healthcare facilities in the United States.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2017 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news
IBS warning: Bloating and stomach pain could actually be too much of THIS
IBS - or irritable bowel syndrome - is a common digestive condition causing stomach pain and bloating. However, symptoms could actually be triggered by an overgrowth of a yeast called candida. (Source: Daily Express - Health)
Source: Daily Express - Health - August 22, 2017 Category: Consumer Health News Source Type: news
Trust distances itself from staffing link to fungus outbreak
A major London hospital trust has sought to distance itself from suggestions that a lack of nursing staff was implicit in an outbreak of the so-called “Japanese fungus” infection Candida auris. (Source: Nursing Times)
Source: Nursing Times - August 17, 2017 Category: Nursing Source Type: news
Lack of nurses blamed for the spread of Japanese fungus
King's College Hospital in South London was responsible for 31 cases of Candida auris fungus infections during a year-long outbreak, figures show. Bosses at its trust blamed a lack of nurses. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2017 Category: Consumer Health News Source Type: news
Tackling an Invasive, Emerging, Multi-drug Resistant Yeast: Candida auris - What Healthcare Providers Need to Know
August 15, 2017 2:00-3:00pm ET. (Source: HSR Information Central)
Source: HSR Information Central - August 11, 2017 Category: International Medicine & Public Health Source Type: news
Saliva 'may speed healing' but 'kissing it better' probably won't
Conclusion
This complex study helps us understand the biological mechanisms behind wound healing in the mouth and the role of saliva in promoting wound healing. As well as keeping the mouth moist and reducing levels of harmful bacteria, saliva contains a protein that encourages the movement of cells in ways that help wounds to heal.
It's possible this might lead to the development of new wound-healing treatments in future; however, this study didn't look at future uses – it simply helps us better understand how the body heals itself.
Before any new treatment could be developed, further studies in cell lines and in animal...
Source: NHS News Feed - August 10, 2017 Category: Consumer Health News Tags: Pregnancy/child Source Type: news
Effect of Split-File Digital Workflow on Crown Margin Adaptation
ConclusionsThe split-file (CD) protocol results in marginal gap size within clinical standards after adjustment; however, 52 of the 60 digitally produced restorations showed a horizontal marginal offset that required adjustment for proper contours. (Source: Dental Technology Blog)
Source: Dental Technology Blog - June 28, 2017 Category: Dentistry Source Type: news
Single fungus amplifies Crohn's disease symptoms
(Case Western Reserve University) A microscopic fungus called Candida tropicalis triggered gut inflammation and exacerbated symptoms of Crohn's disease, in a recent study conducted at Case Western Reserve University School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2017 Category: International Medicine & Public Health Source Type: news
In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
Ann Clin Microbiol Antimicrob. 2013 Dec 5;12:37. doi: 10.1186/1476-0711-12-37.In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.Qiao J, Gao P, Jiang X, Fang H.BACKGROUND:Protein farnesylation is an important tosttranslational modification in fungi. We evaluated the antifungal activity of two farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news
In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
BACKGROUND:Protein farnesylation is an important posttranslational modification in fungi. We evaluated the antifungal activity of two farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.METHODS:Disk diffusion assay and broth microdilution assay were used to determine the antifungal susceptibility of two farnesyltransferase inhibitors (manumycin A and tipifarnib) against clinical isolates of Aspergillus and Candida. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - June 20, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news
Candida auris for the Clinical Microbiology Laboratory: Not Your Grandfather's Candida Species
Candida auris is a newly emerging species that was first identified in Asia in 2009 but has rapidly spread across the world. C. auris differs from most other Candida species in that antifungal resistance is the norm rather than the exception, it is a commensal of human skin rather than the human gut, and it can be easily transmitted from person to person in a health care setting. This review discusses the emergence of C. auris, global epidemiology, identification, antifungal susceptibility testing, and precautions to be taken when it is identified from a patient specimen. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - June 20, 2017 Category: Microbiology Authors: Shawn R. Lockhart, Elizabeth L. Berkow, Nancy Chow, Rory M. Welsh Source Type: news
Transmission of Candida auris in US Health Care Facilities Transmission of Candida auris in US Health Care Facilities
This report details the epidemiology of the first seven U.S. cases of infection with the emerging, and often multidrug-resistant, fungus Candida auris.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 9, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
